Efficacy of anti-inflammatory moisturizer vs hydrophilic cream in elderly patients with moderate to severe xerosis: A split site, triple-blinded, randomized, controlled trial.
Xerosis is a common problem among the elderly, characterized by dry-scaling erythema, fissuring, or pruritus, which could be treated by anti-inflammatory moisturizers without side effects of steroids. We aimed to investigate the efficacy of anti-inflammatory moisturizer (MAS062D lotion) vs hydrophilic cream for the improvement of dry and barrier function skin in xerosis patients. A split site, triple-blinded, randomized, controlled trial was conducted in the elderly with moderate to severe xerosis, who received the 28-day twice daily application of MAS062D lotion and hydrophilic cream on the assigned shins. The evaluations on day 0, 14, and 28 were performed using clinical assessment, skin hydration by corneometer, transepidermal water loss (TEWL), and biometric assessment. There were 24 Thai elderly patients, of whom 87.5% were female (mean age = 58.04 years and mean xerosis severity scale (XSS) = 4.83). Both treatments revealed similar statistically significant improvement in XSS (P < .001). Interestingly, MAS062D lotion-treated side remarkably showed improvement of skin hydration compared with hydrophilic-treated side for 26.86 ± 7.94 vs 25.84 ± 5.1, 41.24 ± 6.92 vs 20.96 ± 6.8, 50.49 ± 8.2 vs 21.75 ± 8.29 at baseline, day 14, and 28, respectively (P-value < .001). Moreover, MAS062D lotion significantly yielded greater decrease in TEWL measurement and more erythema improvement than hydrophilic cream (P-value < .001). No serious adverse effects were observed with either treatment. The MAS062D lotion could potentially be an efficacious treatment for improvement of xerosis in the elderly, which is also safe and refrains from steroid side effects.